Reactions of eosinophilic granulocytes in the sputum and peripheral blood of children suffering from bronchial asthma with signs of eosinophilic and non-eosinophilic inflammation of the bronchi
AbstractThe aim of research was to improve the management of bronchial asthma in children by examining the peculiarities and diagnostic value of reaction markers of eosinophil granulocytes in the sputum and peripheral blood of patients with signs of eosinophil and non-eosinophil phenotypes of this disease. A cohort of 118 school-age children suffering from BA was examined during a period free from attacks. Group I (the main group ) included 61 schoolchildren with signs of eosinophil phenotype (EP) of asthma detected by the character of bronchial inflammation with eosinophil granulocytes present in the sputum at a level of >3%, group II (the comparison group) included 57 patients with a lower number of eosinophils in the sputum (non-eosinophil phenotype (NP) of BA). The average index of the relative content of eosinophils in the peripheral blood among the representatives of group I was 5.82 ± 0.63%, and in children with the signs of NPBA – 6.02 ± 0.74% (P > 0.05), and average indices in the groups of absolute eosinophil number in the blood were 0.37 ± 0.04 and 0.41 ± 0.05 respectively (P > 0.05). The negative reserve of NBT eosinophils in the sputum as a test to verify EPBA showed the following diagnostic values: specificity – 83.3%, predicted value of a positive result – 95.6%. IL-5 content in the blood serum of children with EPBA was 5.99 ± 1.74 ng/ml, in patients of group ІІ – only 1.99 ± 0.49 ng/ml (P < 0.05). Eosinophil cationic protein (ЕСР) in the sputum of patients of group I reached 2.72 ± 0.35 ng/ml, and in the comparison group – only 1.74 ± 0.34 ng/ml (P < 0.05), when the content of ECP in sputum was >1.0 ng/ml the risk of EPBA showed a statistically significant increase: OR = 4.13, RR = 2.02, and AR – 0.34. The efficacy of the standardized basic anti-inflammatory therapy in patients of clinical group I was higher as compared to the children with the signs of NPBA, which was illustrated by the reduced risk of inadequate control of the disease: the index of absolute risk decrease was 31.7%, relative risk – 57.1% with necessary minimal number of patients – 1.75.
Beasley, R., Roche, W. R., Roberts, J. A., & Holgate, S. T. (1989). Cellular events in the bronchi in mild asthma and after bronchial provocation. American Review of Respiratory Disease, 139(3), 806–817. >> doi.org/10.1164/ajrccm/139.3.806
Boulet, L-P., Boulet, V., & Milot, J. (2002). Нow should we quantify asthma control?: A proposal. Chest, 122(6), 2217–2223. >> doi.org/10.1378/chest.122.6.2217
Broide, D. H. (2008). Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. Journal of. Allergy and Clinical Immunology, 121, 560–570. >> /doi.org/10.1016/j.jaci.2008.01.031
Chatila, T. A., Li, N., Garcia-Lioret, M., Kim, H. J., & Nel, A. E. (2008).
T-cell effector pathway in allergic diseases: Transcriptional mechanisms and therapeutic targets. Journal of Allergy and Clinical Immunology, 121, 812–823. >> doi.org/10.1016/j.jaci.2008.02.025
Gibson, P. G., Norzila, M. Z., & Fakes, K. (1999). Pattern of airway inflamma¬tion and its determinants in children with acute severe asthma. Pediatric Pulmonology, 4, 261–270.
Global Initiative for Asthma. Global Strategy for asthma management and prevention, 2016.
Haldar, P., & Pavord, I. D. (2007). Noneosinophilic asthma: A distinct clinical and pathologic phenotype. Journal of Allergy and Clinical Immunology, 119(5), 1043–1052. >> doi.org/10.1016/j.jaci.2007.02.042
Jacobsen, E. A., Lee, N. A., & Lee, J. J. (2014). Re-defining the unique roles for eosinophils in allergic respiratory inflammation. Clinical and Experimental Allergy, 44(9), 1119–1136. >> doi.org/10.1111/cea.12358
Johansson, M. W., Kell, E. A., Busse, W. W., Jarjour, N. N., & Mosher, D. F. (2008). Up-regulation and activation of eosinophil integrins in blood and airway after segmental lung antigen challenge. The Journal of Immunology, 180, 7622–7635. >> doi.org/10.4049/jimmunol.180.11.7622
Kamath, A. V., Pavord, I. D., Ruparelia, P. R., & Chilvers, E. R. (2005). Is the neutrophil the key effector cell in severe asthma? Thorax, 60, 529–530.
Kato, M., Suzuki, M., Hayashi, Y., & Kimura, H. (2006). Role of eosinophils and their clinical significance in allergic inflammation. Expert Review of Clinical Immunology, 2(1), 121–133. >> doi.org/10.1586/1744666X.2.1.121
Kikuchi, S., Nagata, M., & Kikuchi, I. (2005). Association between neutrophilic and eosinophilic inflammation in patients with severe persistent asthma. International Archives of Allergy and Immunology, 137(Suppl. 1), 7–11. >> doi.org/10.1159/000085425
Li, A. M., Lex, C., Zacharasiewicz, A., & Wong, E. (2003). Cough frequency in children with asthma: Correlation with lung function, exhaled nitric oxide, and sputum eosinophil count. Thorax, 58, 974–978. >> doi.org/10.1136/thorax.58.11.974
Litvinova, L. S., Kolobovnikova, Y. V., Knutareva, Е. N., Grigoryeva, E. S., Suvorova, E. V., Novitskiy, V. V., & Riazantseva, N. V. (2006). Cytotoxic potential of eosinophilic granulocytes in patients with eosinophilic syndrome. Newsletter of Siberian Medicine, 5(3), 26–30.
Madison, J. M., & Schramm, C. M. (2000). Cationic proteins and bronchial hyperresponsiveness. American Journal of Respiratory Cell and Molecular Biology, 22(5), 513–516. >> doi.org/10.1165/ajrcmb.22.5.f183
Mann, B. S., & Chung, K. F. (2006). Blood neutrophil activation markers in severe asthma: Lack of inhibition by prednisolone therapy. Respiratory Research, 7, 59. >> doi.org/10.1186/1465-9921-7-59
Motojima, S., Frigas, E., Loegering, D. A., & Gleich, G. J. (1989). Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. American Review of Respiratory Disease, 139(3), 801–805. >> doi.org/10.1164/ajrccm/139.3.801
Novitskiy, V. V., Riazantseva, N. V., Litvinova, L. S., Kolobovnikova, Y. V., Grigoryeva, E. S., & Suvorova, E. V. (2006). The mechanisms of disorders of eosinophils and immunocytes in the formation of gross blood eosinophilia. Newsletter of Siberian Medicine, 2, 32–34.
Pavord, I. D., 2013. Eosinophilic phenotypes of airway disease. ATS Journal, 10, 143–149. >> doi.org/10.1513/AnnalsATS.201306-168AW
Ponikau, J. U., Winter, L. A., Kephart, G. M., Squillace, D. L., & Hershcovitch, M. D. (2015). An immunologic test for chronic rhinosinusitis based on free intranasal eosinophilic major basic protein. International Forum of Allergy & Rhinology, 5(1), 28–35. >> doi.org/10.1002/alr.21421
Shirai, T., Inui, N., & Chida, K. (2006). Correlation between peripheral blood T-cell profiles and airway inflammation in atopic asthma. Journal of Allergy and Clinical Immunology, 118, 622–626. >> doi.org/10.1016/j.jaci.2006.05.005
Wenzel, S., 2003. Mechanism of severe asthma. Clinical and Experimental Allergy, 33, 1622–1628. >> doi.org/10.1111/j.1365-2222.2003.01799
Wilson, N. M., Bridge, P., Spanevello, A., & Silverman, M. (2000). Induced sputum in children: Feasibility, repeatability, and relation of findings to asthma severity. Thorax, 55, 768–774. >> doi.org/10.1590/S0021-75572005000400008
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.